Going Mobile with Clinical Trials
Liz Logan, Head of the MCT-Congress, gives Journal for Clinical Studies an insight into the business of mobile technology in…
Liz Logan, Head of the MCT-Congress, gives Journal for Clinical Studies an insight into the business of mobile technology in…
Digitalization of healthcare is unstoppable, as it provides increased adherence, better health outcomes and – ultimately – billions of pounds…
The growing complexities of the drug development process, toughening drug safety standards, increased regulatory scrutiny, and ongoing patent cliff have…
With continued efforts to improve clinical processes, risk-based monitoring (RBM) approaches are becoming increasingly important for sponsors and CROs. Petra…
In recent years, behavioural health agencies have begun to apply the outcomes-based measurements found in medicine to improve their ability…
Martin Lamb of Biotec Services International proves there are ways in which a little extra time spent on up-front planning…
Currently, the global biosimilars market includes monoclonal antibody (mAb) biosimilars for the treatment of cancer and autoimmune conditions (e.g., rheumatoid…
Owing to a large population base, the prevalence of various dermatological disorders in India is fairly high, even for uncommon…
With a bustling population composed of a mixture of expats and locals, and the topic of clinical research not being…
Currently more than 45% of the whole continent’s clinical trials are being conducted in South Africa, hence the need for…